Cardiovascular Disease Doctors in Yonkers, NY Accepting Medicare

26 Cardiovascular Disease doctors found. Showing 21 - 26

Alon Gitig, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1010 N Broadway, Yonkers, NY 10701 Phone: 914-423-8115

Dr. Douglas Hart, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 73 Market St, Yonkers, NY 10710 Phone: 914-831-6880    Fax: 914-831-6881

Dr. Rohan L Wijetilaka, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 944 N Broadway, Suite 203, Yonkers, NY 10701 Phone: 914-963-2484    Fax: 914-963-3674

David Sternheim, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 73 Market St, Yonkers, NY 10710 Phone: 914-305-2700    Fax: 914-831-6881

David Mack, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 967 N Broadway, Yonkers, NY 10701 Phone: 914-966-9787    Fax: 914-966-9793

Richard Feldman, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 127 S Broadway, Suite 200, Yonkers, NY 10701 Phone: 914-378-7583    Fax: 914-378-7129

News Archive

Unemployment barrier to antidiabetic medication adherence

People with diabetes are less likely to adhere to their oral antidiabetic medication if they are unemployed, report researchers.

Genspera to commence G-202 Phase I trial following FDA approval

GenSpera, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to begin a Phase I study with its target activated pro-drug, G-202, for the treatment of cancer.

Gilead to boost price of new hepatitis c drug

Gilead Sciences says its next generation drug to combat hepatitis C, slated to launch next month, will be more expensive than $1,000-a-pill Sovaldi, in part because the new treatment will be shorter and simpler. Gilead also struck a deal with Indian generic drugmakers to sell lower-cost versions of Sovaldi in poor countries.

Running continuously over 50 or 100 miles may not be good for the heart: Study

In 2009, a study was conducted in UK by Liverpool John Moores University and the Countess of Chester Hospital to assess the effects of running in ultra-endurance races. Typically aimed at super-fit and experienced athletes, these races are held over distances exceeding 50 miles (80 kilometres). The conclusions suggest that some damage is likely to occur to the heart muscle of competitors, while 12 percent of the study group showed signs of significant cardiac damage.

DFG approves establishment of new CRCs; research topics range from modern prostheses to political reforms to marine bacteria

The DFG has approved the establishment of 17 new Collaborative Research Centres as of 1 January 2010. This decision was made recently by the relevant Grants Committee in Bonn.

Read more Medical News

› Verified 4 days ago

• 1
• 2(current)